Going Beyond Results of the PEMBRO-RT Trial-Reply

Affiliations

Comment

Willemijn S M E Theelen et al. JAMA Oncol. 2020.

. 2020 Jan 1;6(1):162.

doi: 10.1001/jamaoncol.2019.5034.

¹ Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

No abstract available

Comment on

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial.
Theelen WSME, Peulen HMU, Lalezari F, van der Noort V, de Vries JF, Aerts JGJV, Dumoulin DW, Bahce I, Niemeijer AN, de Langen AJ, Monkhorst K, Baas P. Theelen WSME, et al. JAMA Oncol. 2019 Sep 1;5(9):1276-1282. doi: 10.1001/jamaoncol.2019.1478. JAMA Oncol. 2019. PMID: 31294749 Free PMC article.
Going Beyond Results of the PEMBRO-RT Trial.
Yang X, Men Y, Hui Z. Yang X, et al. JAMA Oncol. 2020 Jan 1;6(1):160-161. doi: 10.1001/jamaoncol.2019.5028. JAMA Oncol. 2020. PMID: 31750857 No abstract available.
Going Beyond Results of the PEMBRO-RT Trial.
Zhang B, Han B. Zhang B, et al. JAMA Oncol. 2020 Jan 1;6(1):161-162. doi: 10.1001/jamaoncol.2019.5031. JAMA Oncol. 2020. PMID: 31750867 No abstract available.